Clinical highlights from the 2025 MR-Linac Consortium meeting
Session 1:
4 Dec 2025 15:00 GMT
Thursday, 04 December 2025 3:00 PM GMT
Thursday, 04 December 2025 4:00 PM Europe/Warsaw
Session 2:
5 Dec 2025 03:00 GMT
Friday, 05 December 2025 3:00 AM GMT
Friday, 05 December 2025 4:00 AM Europe/Warsaw
Get up to date with the latest clinical trends and advancements in MR-guided radiotherapy (MRgRT), directly from the experts who were there.
Highlights include:

Highlights of the 20th MR-Linac Consortium meeting
Veronica Dell‘Acqua, MD
Elekta

Adaptive 5-fraction radiotherapy for glioblastoma: A comparative analysis of clinical efficacy and patient burden
Zabi Wardak, MD
UT Southwestern Medical Center, Dallas, USA

Safety and efficacy of unresectable malignant cardiac tumors treated with concurrent chemoradiation therapy
Prof. Hui Liu, MD
Sun Yat-sen University Cancer Center, China

Erectile function preservation with neurovascular-sparing MRgRT for localized prostate cancer: preliminary results of the ERECT trial after 18 months follow-up
Tariq Lalmahomed, MD
UMC Utrecht, The Netherlands

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan
Tomas Janssen, PhD
NKI/AvL, The Netherlands